passage bio inc stock

No significant news for in the past two years. It might be of some concern to shareholders to see the Passage Bio Inc.

Imagem Gratis No Pixabay Corredor Vidro Tunel Direcao Information Technology Architecture Stock Images Free Free Stock Photos

Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of Passage Bio Inc.

. The firm said the companys gene ther. PASG share price down -032 in the last day. See Passage Bio Inc.

Get Passage Bio Incs stock price today. Common Stock PASG Real-time Stock Quotes - Nasdaq offers real-time quotes market activity data for US and global markets. Find the latest Passage Bio Inc.

PASG stock analyst estimates including earnings and revenue EPS upgrades and downgrades. So far 250546 shares have traded compared to average volume of 369611 shares. Item 801 Other Events.

Passage Bio Inc. ET by Tomi Kilgore Passage Bio downgraded to neutral from overweight at JP. The potential of gene therapy is unlimited but potential doesnt save livesmedicines do.

PASG Nasdaq Global Select PASG 344 020 62 Price as of February 25 2022 400 pm. PASG shares are trading higher after Raymond James initiated coverage on the stock with an Outperform rating and announced a 29 price target. Passage Bio Inc NASDAQ Updated Apr 8 2022 803 PM.

Porter MD Elected to Board of Directors of Passage Bio. The stock has traded between 328 and 356 so far today. The Company will decrease operating expenses by reducing the workforce by approximately 13 percent and prioritizing its research and development programs in partnership with the University of.

Is Passage Bio Inc. On March 15 2022 Passage Bio Inc. The stock has traded between 328 and 356 so far today.

Find the latest SEC Filings data for Passage Bio Inc. NASDAQPASG Get Rating CEO Bruce A. PASG stock quote history news and other vital information to help you with your stock trading and investing.

PASG stock quote chart and news. PASG 323 023 665. News Passage Bio Inc.

On average Wall Street analysts predict. Passage Bio Inc PASG stock is trading at 347 as of 326 PM on Thursday Apr 7 an increase of 017 or 515 from the previous closing price of 330. The Company announced an update on its strategic priorities to extend its cash runway.

Is followed by the analysts listed above. Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business. Is a clinical-stage genetic medicines company.

PASG Stock Price News Info The Motley Fool Passage Bio Inc. Learn more about our company. It is focused on developing transformative therapies for central nervous system CNS disorders.

Fulfilling the promise of gene therapy. That PASSAGE BIOs share price could reach 1833 by Mar 8 2023. Is a clinical-stage genetic medicines company.

Passage Bio Inc. 9 months ago - Benzinga Derrell D. The company was incorporated in 2017 and is headquartered in Philadelphia Pennsylvania.

Its first product candidate PBGM01 utilizes AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta-galactosidase Î²-gal for gangliosidosis GM1. Our focus is on producing medicines that will transform the lives of patients and their families. Volume today is low.

Passage Bio NASDAQ. PASG a Stock to Watch After Losing -032 on Tuesday. 25 2021 at 722 am.

Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business. Key Stock Data PE Ratio TTM NA EPS TTM -347 Market Cap 15473 M Shares Outstanding 5429 M. The average PASSAGE BIO stock price prediction forecasts a potential upside of 49139 from the current PASG share price of 310.

Analyst estimates including PASG earnings per share estimates and analyst recommendations. It is focused on developing transformative therapies for central nervous system CNS disorders. Passage Bio started at outperform with 26 stock price target at Wedbush Jan.

Goldsmith purchased 10000 shares of the firms stock in a transaction that occurred on. Its first product candidate PBGM01 utilizes AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta-galactosidase ß-gal for gangliosidosis GM1. Posted by MarketBeat News on Mar 24th 2022 Passage Bio Inc.

1434 23 March 2022 Learn more about. Stock Price Quote NASDAQPASG 323 -665 Friday 8th Apr 2022. Passage Bio Inc PASG stock is trading at 347 as of 326 PM on Thursday Apr 7 an increase of 017 or 515 from the previous closing price of 330.

Passage Bio Inc Pasg Stock Price News Info The Motley Fool